Luigi Barbato
Researcher, Novartis Pharmaceuticals Corporation, East Hanover, USA
Dr.Barbato working in Novarties Pharmaceuticals Corporation,USA.Dr.Barbato research intrests are Outcomes of a Switch to Fingolimod to Treat Relapsing Multiple Sclerosis,A Patient Subgroup Post Hoc Analysis.Dr.Barbato international experience includes various programs, contributions and participation in different countries for diverse fields of study.
Beck Depression Inventory-II, Clinical Global Impressions of Improvement,Fatigue Severity Scale, Fingolimod , Multiple sclerosis,Treatment Satisfaction Questionnaire for Medication.